TriMas Corporation (FRA:MQ1)

Intra-Cellular Therapies Statistics

Total Valuation

TriMas has a market cap or net worth of EUR 1.23 billion. The enterprise value is 1.63 billion.

Market Cap	1.23B
Enterprise Value	1.63B

Important Dates

The last earnings date was Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	May 6, 2025

Share Statistics

Current Share Class	40.64M
Shares Outstanding	n/a
Shares Change (YoY)	-1.11%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	31.63M

Valuation Ratios

The trailing PE ratio is 38.69 and the forward PE ratio is 15.82.

PE Ratio	38.69
Forward PE	15.82
PS Ratio	1.48
PB Ratio	2.02
P/TBV Ratio	8.82
P/FCF Ratio	45.51
P/OCF Ratio	16.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.97, with an EV/FCF ratio of 60.40.

EV / Earnings	51.35
EV / Sales	1.93
EV / EBITDA	12.97
EV / EBIT	28.42
EV / FCF	60.40

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.69.

Current Ratio	2.59
Quick Ratio	1.29
Debt / Equity	0.69
Debt / EBITDA	3.40
Debt / FCF	15.59
Interest Coverage	3.59

Financial Efficiency

Return on equity (ROE) is 5.36% and return on invested capital (ROIC) is 3.51%.

Return on Equity (ROE)	5.36%
Return on Assets (ROA)	2.95%
Return on Invested Capital (ROIC)	3.51%
Return on Capital Employed (ROCE)	5.27%
Revenue Per Employee	212,622
Profits Per Employee	8,146
Employee Count	3,900
Asset Turnover	0.69
Inventory Turnover	3.54

Taxes

In the past 12 months, TriMas has paid 10.54 million in taxes.

Income Tax	10.54M
Effective Tax Rate	24.91%

Stock Price Statistics

The stock price has increased by +18.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.25%
50-Day Moving Average	24.32
200-Day Moving Average	22.71
Relative Strength Index (RSI)	87.31
Average Volume (20 Days)	82

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.12

Income Statement

In the last 12 months, TriMas had revenue of EUR 829.22 million and earned 31.77 million in profits. Earnings per share was 0.77.

Revenue	829.22M
Gross Profit	187.32M
Operating Income	56.43M
Pretax Income	42.31M
Net Income	31.77M
EBITDA	111.50M
EBIT	56.43M
Earnings Per Share (EPS)	0.77

Balance Sheet

The company has 25.78 million in cash and 421.08 million in debt, giving a net cash position of -395.30 million.

Cash & Cash Equivalents	25.78M
Total Debt	421.08M
Net Cash	-395.30M
Net Cash Per Share	n/a
Equity (Book Value)	609.05M
Book Value Per Share	14.99
Working Capital	255.77M

Cash Flow

In the last 12 months, operating cash flow was 75.40 million and capital expenditures -48.39 million, giving a free cash flow of 27.01 million.

Operating Cash Flow	75.40M
Capital Expenditures	-48.39M
Free Cash Flow	27.01M
FCF Per Share	n/a

Margins

Gross margin is 22.59%, with operating and profit margins of 6.81% and 3.83%.

Gross Margin	22.59%
Operating Margin	6.81%
Pretax Margin	5.10%
Profit Margin	3.83%
EBITDA Margin	13.45%
EBIT Margin	6.81%
FCF Margin	3.26%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.49%.

Dividend Per Share	0.15
Dividend Yield	0.49%
Dividend Growth (YoY)	-0.98%
Years of Dividend Growth	n/a
Payout Ratio	17.66%
Buyback Yield	1.11%
Shareholder Yield	1.60%
Earnings Yield	2.58%
FCF Yield	2.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TriMas has an Altman Z-Score of 1.95 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.95
Piotroski F-Score	5